Background illustration for clinical trials search

Paid Clinical Trials Meridian

Discover 224 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

The Fourth Left Atrial Appendage Occlusion Study

for
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Location: Boise ID, Coeur d'Alene ID, Tacoma WA, Sacramento CA,
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Boise ID, Murray UT, Portland OR, Seattle WA,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701656

Phase 2, Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Boise ID, Spokane WA, Salt Lake City UT, Portland OR,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase 3, Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Boise ID, Murray UT, Portland OR, Seattle WA,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701669

Phase 2, Recruiting

A Study to Assess Growth in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: Boise ID, Idaho Falls ID, Sacramento CA,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 2 - 16

Code: NCT06309979

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Boise ID, Salt Lake City UT, Seattle WA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase 3, Recruiting

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Boise ID, Seattle WA, Calgary, Lakewood CO, Denver CO,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase 3, Recruiting

Pain Management Teams Using Whole Health to Optimize Function and Safety in Veterans: The TEAMWORK Trial

for
Chronic Pain
Location: Boise ID, Aurora CO, Birmingham AL, West Haven CT
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT07149870

Recruiting

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

for
Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnea,
Location: Boise ID, Spokane WA, Seattle WA, Minneapolis MN,
Sponsor: Seattle Institute for Biomedical and Clinical Research

Sex: All

Age: 18+

Code: NCT06390345

Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: Boise ID, Salt Lake City UT, Portland OR, Sacramento CA,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase 3, Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for
Growth Hormone Deficiency
Location: Boise ID, Portland OR, Seattle WA, Sacramento CA,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 1 - 18

Code: NCT05775523

Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for
Growth Hormone Deficiency
Location: Boise ID, Portland OR, Seattle WA, Sacramento CA,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 0+

Code: NCT05820672

Recruiting

A Study of MF101 in Postmenopausal Women

for
Hot Flushes, Vasomotor Symptoms
Location: Boise ID, West Jordan UT, Eugene OR, Medford OR,
Sponsor: Bionovo

Sex: Female

Age: 40 - 65

Code: NCT00906308

Phase 3, Recruiting

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

for
Overweight, Obesity
Location: Meridian ID, Layton UT, Escondido CA, Fargo ND,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 8 - 18

Code: NCT07253285

Phase 3, Recruiting

A Long-Term Follow-Up Study of Participants Exposed to REACT

for
Diabetic Kidney Disease, Chronic Kidney Diseases
Location: Meridian ID
Sponsor: Prokidney

Sex: All

Age: 30 - 70+

Code: NCT05918523

Recruiting

Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome

for
Shoulder Pain
Location: Boise ID
Sponsor: Injury Care Medical Center

Sex: All

Age: 18+

Code: NCT01544283

Phase 2, Recruiting

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

for
Pruritus
Location: Boise ID, Calgary, La Jolla CA, Fargo ND, Bellevue NE,
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT05263206

Phase 3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Boise ID, Spokane WA, Sacramento CA, Surrey, Vancouver,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase 3, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: Boise ID, Los Angeles CA, Fountain Valley CA,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase 3, Recruiting

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

for
Chronic Lymphocytic Leukemia
Location: Boise ID, Logan UT, Carson City NV, Stockton CA,
Sponsor: East Valley Hematology and Oncology Medical Group

Sex: All

Age: 18+

Code: NCT00131313

Recruiting